CureVac N.V. (CVAC) Earnings History
Annual and quarterly earnings data from 2018 to 2024
Loading earnings history...
CVAC EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
CVAC Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 80.2% | 33.2% | 30.3% |
| 2023 | -131.3% | -510.1% | -484.0% |
| 2022 | -172.9% | -370.0% | -369.4% |
| 2021 | -131.3% | -400.3% | -399.8% |
| 2020 | 71.0% | -253.6% | -264.0% |
Download Data
Export CVAC earnings history in CSV or JSON format
Free sign-in required to download data
CureVac N.V. (CVAC) Earnings Overview
As of May 6, 2026, CureVac N.V. (CVAC) reported trailing twelve-month net income of $194M, reflecting +161.0% year-over-year growth. The company earned $0.86 per diluted share over the past four quarters, with a net profit margin of 30.3%.
Looking at the long-term picture, CVAC's historical earnings data spans multiple years. The company achieved its highest annual net income of $162M in fiscal 2024, representing a new all-time high.
CureVac N.V. maintains industry-leading profitability with a gross margin of 80.2%, operating margin of 33.2%, and net margin of 30.3%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including MRNA (-$3.19B net income, -145.2% margin), BNTX (-$1.13B net income, -39.6% margin), ARCT (-$66M net income, -97.9% margin), CVAC has outperformed on profitability metrics. Compare CVAC vs MRNA →
CVAC Earnings vs Peers
Earnings metrics vs comparable public companies
CVAC Historical Earnings Data (2018–2024)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $162M | +162.3% | $178M | $0.72 | 30.3% | 33.2% |
| 2023 | -$260M | -4.5% | -$274M | $-1.18 | -484.0% | -510.1% |
| 2022 | -$249M | +39.5% | -$249M | $-1.32 | -369.4% | -370.0% |
| 2021 | -$412M | -219.0% | -$412M | $-2.21 | -399.8% | -400.3% |
| 2020 | -$129M | -29.2% | -$124M | $-0.98 | -264.0% | -253.6% |
| 2019 | -$100M | -40.2% | -$99M | $-0.53 | -573.5% | -571.3% |
| 2018 | -$71M | - | -$73M | $-0.40 | -553.5% | -565.8% |
See CVAC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CVAC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CVAC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCVAC — Frequently Asked Questions
Quick answers to the most common questions about buying CVAC stock.
Is CVAC growing earnings?
CVAC EPS is $0.86, with earnings growth accelerating to +161.0%. This exceeds the 5-year CAGR of N/A. TTM net income reached $194M.
What are CVAC's profit margins?
CureVac N.V. net margin is +30.3%, with operating margin at +33.2%. Above-average margins indicate pricing power.
How consistent are CVAC's earnings?
CVAC earnings data spans 2018-2024. The accelerating earnings trend is +161.0% YoY. Historical data enables comparison across business cycles.